Novo Nordisk (NVO) closed the most recent trading day at $38.70, moving -1.11% from the previous trading session. The stock fell short of the S&P 500, which registered a gain of 0.6% for the day. Meanwhile, the Dow gained 0.03%, and the Nasdaq, a tech-heavy index, added 1.18%. The drugmaker's stock has climbed by 1.09% in the past month, falling short of the Medical sector's gain of 2.23% and outpacing the S&P 500's loss of 0.79%. The investment community will be paying close attention to the earnings performance of Novo Nordisk in its upcoming release. The company is slated to reveal its earnings on November 4, 2026. The company is predicted to post an EPS of $0.81, indicating a 20.59% decline compared to the equivalent quarter last year.
Publicznie pokazujemy glowna mysl. Utworz darmowe konto, aby czytac caly artykul, zapisac go, omowic i polaczyc z kontekstem rynkowym oraz OSINT.